Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Pulmonary emphysema
MeSH D011656 - pulmonary emphysema
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D029424:
Chronic obstructive pulmonary disease
18 Companies
14 Drugs
$
Success rate
D011656:
Pulmonary emphysema
99 Companies
21 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Alembic Pharmaceuticals
Arformoterol
Arformoterol
2022-05-10
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/1
Phase 3
90
%
9/10
Approved:
9
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Arbor Pharmaceuticals
Acetylcysteine
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use